NEW YORK, NY (February 17, 2023) — Tom Maniatis, PhD, Evnin Family Scientific Director and CEO of the New York Genome Center (NYGC) was recently interviewed by Brian Gormley of The Wall Street Journal on the impact of new, lower-cost DNA-sequencing technologies on clinical care and research. Access the full article here.
The New York Genome Center (NYGC) is proud to have collaborated on this multi-institutional article which addresses the requirements for integrating whole-genome transcriptome sequencing into health care systems. NEW YORK, NY (January 25, 2023)– How can whole-genome transcriptome sequencing (WGTS) be integrated into health care systems to replace the standard of care for oncology? The […]
Columbia Biomedical Engineering Department, the Irving Institute for Cancer Dynamics, and the New York Genome Center welcome new faculty member, Sanja Vicković, PhD. NEW YORK, NY (July 1, 2022) — Dr. Sanja Vicković’s path to cancer research was not a traditional one. Born and raised in Croatia, a professional ice hockey career brought her from […]
